Sagar Lonial, MD from Winship Cancer Institute of Emory University discusses trial combines Daratumumab with Carfilzomib & Dexamethasone and the first trial combining all drugs in a larger patient experience at the 2017 American Society of Hematology.
Trial Combines Daratumumab with Carfilzomib & Dexamethasone – First Trial combining all drugs in a larger patient experience
